B-8805-033

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameB-8805-033
Drug Alias NameB-8805-033
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1a adrenergic receptor antagonistsSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptorAlpha-1a adrenergic receptor
Therapy Area/IndicationsUrination DisordersProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecordati Industria Chimica E Farmaceutica Spa
Active IndicationsN/A
Inactive IndicationsUrination DisordersProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A